Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 355 | 571 | 386 | 514 | 1,241 |
| Cost of Goods | 114 | 102 | 75 | 94 | 123 |
| Gross Profit | 241 | 469 | 311 | 420 | 1,118 |
| Operating Expenses | 6,237 | 7,296 | 6,788 | 7,952 | 8,113 |
| Operating Income | -5,882 | -6,725 | -6,402 | -7,438 | -6,872 |
| Other Income | 6,866 | -1,225 | -128 | -990 | 1,532 |
| Pre-tax Income | 984 | -7,950 | -6,530 | -8,428 | -5,340 |
| Income Tax | -1,061 | -178 | N/A | N/A | -784 |
| Net Income Continuous | 2,045 | -7,772 | -6,530 | -8,428 | -4,556 |
| Minority Interests | 13 | -12 | -8 | -29 | -74 |
| Net Income | $2,032 | $-7,760 | $-6,522 | $-8,399 | $-4,482 |
| EPS Basic Total Ops | 0.01 | -0.05 | -0.04 | -0.06 | -0.07 |
| EPS Basic Continuous Ops | 0.01 | -0.05 | -0.04 | -0.06 | -0.07 |
| EPS Diluted Total Ops | 0.01 | -0.05 | -0.04 | -0.06 | -0.07 |
| EPS Diluted Continuous Ops | 0.01 | -0.05 | -0.04 | -0.06 | -0.07 |
| EBITDA(a) | $-5,521 | $-6,447 | $-5,849 | $-6,719 | $-6,068 |